CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Xeris Pharmaceuticals Inc Company Snapshot
Xeris Pharmaceuticals Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Xeris Pharmaceuticals Inc with three other companies in this sector in the United States: Ardelyx Inc (2018 sales of $2.61 million of which 100% was Development of Biopharmaceutical Product), Liquidia Technologies Inc ($2.71 million ), and Crinetics Pharmaceuticals Inc ($2.43 million of which 100% was Pharmaceutical Preparations).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Xeris Pharmaceuticals Inc
  Stock Performance Chart for Xeris Pharmaceuticals Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/18/2019): 9.01
(Figures in U.S. Dollars)
1 Week 14.8%   13 Weeks -11.9%  
4 Weeks -26.6%   52 Weeks -54.8%  
 
Xeris Pharmaceuticals Inc Key Data:
  Ticker: XERS Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 2,465,000
(Year Ending Jan 2019).
Employees: 90
  Currency: U.S. Dollars Market Cap: 243,156,033
  Fiscal Yr Ends: December Shares Outstanding: 26,987,351
  Share Type: Common Closely Held Shares: 1,791,597
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.